Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Marinus Pharmaceuticals, Inc. (MRNS)

« Back to company index

MRNS Chatter Timeline

Stock Ticker for MRNS

Most Active Tweeters for MRNS

UserTweets
@secalerts4u 6
@MysteriousMole1 6
@Tickeron 4
@quantisnow 3
@otcdynamics 3

Recent Tweets for MRNS

intratio @intratio
$MRNS https://t.co/OUo56XurEF Marinus Pharmaceuticals Inc The statistical model is forecasting the market value of… https://t.co/RzSFXutBUf
August 4th 2021, 11:08pm
Tickeron @Tickeron
$MRNS's price moved below its 50-day Moving Average on July 13, 2021. View odds for this and other indicators:… https://t.co/Mtbuv1xtsm
August 4th 2021, 6:08pm
MysteriousMole1 @MysteriousMole1
$MRNS https://t.co/EBi1U5wi8V
August 4th 2021, 3:08pm
BioWino @BioWino
$mrns penalty box on delay
August 4th 2021, 2:08pm
mike1v @mike1v
Marinus $MRNS received a Buy rating and $38 price target from H.C. Wainwright 5-star Analyst Douglas Tsao (H.C. Wai… https://t.co/HSIIcKO8kB
August 4th 2021, 10:08am
ShortAlgoTrades @ShortAlgoTrades
$MRNS Now awaiting Buy signal. Got to love the UltraAlgo for beating the pump and dump game! https://t.co/6IlmmkaczU
August 4th 2021, 1:08am
EZMoney_41 @EZMoney_41
$MRNS Now awaiting Buy signal. https://t.co/sX3MNozdY4
August 4th 2021, 1:08am
ShortAlgoTrades @ShortAlgoTrades
$MRNS waiting for buy signal on MRNS. Learn more at https://t.co/ZzhEUJ8ooJ https://t.co/86OcKe58fc
August 4th 2021, 12:08am
otcdynamics @otcdynamics
$MRNS Marinus Pharmaceuticals to Provide Business Update and Announce Second Quarter 2021 Financial Results on Augu… https://t.co/zitJtsn3D5
August 3rd 2021, 8:08pm
FlashAlert_me @FlashAlert_me
$MRNS [15s. delayed]: Issued Press Release on August 03, 16:00:00: Marinus Pharmaceuticals to Provide Business Upda… https://t.co/OdbKp12YHs
August 3rd 2021, 8:08pm
StockNewsBot2 @StockNewsBot2
$MRNS Marinus Pharmaceuticals to Provide Business Update and Announce Second Quarter 2021 Financial Results on Augu… https://t.co/yJNHMmsNoA
August 3rd 2021, 8:08pm
secalerts4u @secalerts4u
$MRNS - Marinus Pharmaceuticals to Provide Business Update and Announce Second Quarter 2021 Financial Results https://t.co/8ehGdZ6lOk
August 3rd 2021, 8:08pm
quantisnow @quantisnow
$MRNS ? Marinus Pharmaceuticals to Provide Business Update and Announce Second Quarter 2021 Financial Results on Au… https://t.co/F5woNBFACW
August 3rd 2021, 8:08pm
stock_titan @stock_titan
$MRNS Marinus Pharmaceuticals to Provide Business Update and Announce Second Quarter 2021 Financial Results on Augu… https://t.co/Nat11U2Dho
August 3rd 2021, 8:08pm
MarcJacksonLA @MarcJacksonLA
$MRNS Marinus Pharmaceuticals Submits New Drug Application (NDA) to FDA for Ganaxolone for the Treatment of Seizure… https://t.co/XJftnmhxV6
August 3rd 2021, 7:08pm
pbindler @pbindler
$MRNS Looks like delayed enrollment trumps NDA filing and partnership. Investors fearing a raise?
August 3rd 2021, 7:08pm
BioWino @BioWino
guess $mrns in penalty box forever now. wake me up in single digits i guess. probably in 2 weeks
August 3rd 2021, 5:08pm
IOInvestors @IOInvestors
Marinus Pharmaceuticals $MRNS Announces Collaboration with Orion Corporation for European Commercialization of Gana… https://t.co/LdVZVBejSs
August 3rd 2021, 5:08pm
SmallCapsDaily @SmallCapsDaily
$MRNS Marinus Pharmaceuticals Announces Exclusive Collaboration with Orion Corporation for European Commercializati… https://t.co/MneMFDDikD
August 3rd 2021, 4:08pm
MarcJacksonLA @MarcJacksonLA
$MRNS Marinus Pharmaceuticals Announces Exclusive Collaboration with Orion Corporation for European Commercializati… https://t.co/5os0lHdysE
August 3rd 2021, 2:08pm
MarcJacksonLA @MarcJacksonLA
$MRNS Marinus Pharmaceuticals Submits NDA to FDA for Seizure Treatment https://t.co/Za6l69o94J
August 3rd 2021, 2:08pm
MysteriousMole1 @MysteriousMole1
$ORNAV Orion Corp (>€1bn revs) PR on the licensing deal with $MRNS to commercialize oral & IV GNX in Europe; €25m u… https://t.co/APh4wenOCf
August 3rd 2021, 2:08pm
Briefingcom @Briefingcom
$MRNS: Marinus Pharmaceuticals submits NDA for the use of ganaxolone to treat seizures associated with CDKL5... https://t.co/UlPioRu2Km
August 3rd 2021, 1:08pm
Briefingcom @Briefingcom
$MRNS: Marinus Pharmaceuticals announces collaboration with Orion Corporation for commercialization of ganaxolone i… https://t.co/52p9szkGm8
August 3rd 2021, 1:08pm
biostockinfo @biostockinfo
RT @BioStocks: $MRNS Submits NDA for Ganaxolone for the Treatment of Seizures Associated with CDKL5 - requests Priority Review. NDA accept…
August 3rd 2021, 12:08pm
MysteriousMole1 @MysteriousMole1
$MRNS https://t.co/pBnHnTgGvz
August 3rd 2021, 12:08pm
TraderSilver1 @TraderSilver1
RT @MysteriousMole1: $MRNS
August 3rd 2021, 12:08pm
BioStocks @BioStocks
$MRNS Submits NDA for Ganaxolone for the Treatment of Seizures Associated with CDKL5 - requests Priority Review. N… https://t.co/7q3lpICg0K
August 3rd 2021, 12:08pm
MysteriousMole1 @MysteriousMole1
$MRNS NDA for GNX in CDD includes request for priority review; since GNX was awarded rare pediatric designation in… https://t.co/8XOMETNyzW
August 3rd 2021, 12:08pm
QuantchaIdeas @QuantchaIdeas
StockTwits Trending Alert: Trading recent interest in MARINUS PHARMACEUTICALS INC. $MRNS https://t.co/IA5C4xdHON
August 3rd 2021, 12:08pm
OpenOutcrier @OpenOutcrier
$MRNS (+6.4% pre) Marinus Pharmaceuticals Submits New Drug Application (NDA) to FDA for Ganaxolone for the Treatmen… https://t.co/p164heC6iV
August 3rd 2021, 11:08am
secalerts4u @secalerts4u
$MRNS - Marinus Pharmaceuticals Submits NDA to FDA for Seizure Treatment https://t.co/zx4perKdiW
August 3rd 2021, 11:08am
MysteriousMole1 @MysteriousMole1
$MRNS https://t.co/xffuB7sBgL
August 3rd 2021, 11:08am
secalerts4u @secalerts4u
$MRNS - Marinus Pharma submits ganaxolone application in U.S. for seizures due to rare, genetic epilepsy https://t.co/pkhKzI1tXH
August 3rd 2021, 11:08am
AglowStockNews @AglowStockNews
$MRNS Marinus Pharma submits ganaxolone application in U.S. for seizures due to rare, genetic epilepsy #StockMarket #StocksToBuy
August 3rd 2021, 11:08am
ethanFlare @ethanFlare
$MRNS - Marinus Pharma submits ganaxolone application in U.S. for seizures due to rare, genetic epilepsy Cap size:… https://t.co/PEJn79EUVF
August 3rd 2021, 11:08am
MarketCurrents @MarketCurrents
$MRNS - Marinus Pharma submits ganaxolone application in U.S. for seizures due to rare, genetic epilepsy https://t.co/Ycw0t50VM8
August 3rd 2021, 11:08am
otcdynamics @otcdynamics
$MRNS Marinus Pharmaceuticals Submits New Drug Application (NDA) to FDA for Ganaxolone for the Treatment of Seizure… https://t.co/BXQaWMgLz5
August 3rd 2021, 11:08am
otcdynamics @otcdynamics
$MRNS Marinus Pharmaceuticals Announces Exclusive Collaboration with Orion Corporation for European Commercializati… https://t.co/6vIhQMsD8e
August 3rd 2021, 11:08am
EdgarInsider @EdgarInsider
Filing for 8-K [Press/News Current Report] has been made with the SEC: $MRNS MARINUS PHARMACEUTICALS INC https://t.co/V8GQQRKUsr
August 3rd 2021, 11:08am
StockNewsBot2 @StockNewsBot2
$MRNS Marinus Pharmaceuticals Announces Exclusive Collaboration with Orion Corporation for European Commercializati… https://t.co/3BjKEGASFC
August 3rd 2021, 11:08am
secalerts4u @secalerts4u
$MRNS - Marinus Pharmaceuticals Announces Exclusive Collaboration with Orion Corporation for European https://t.co/F7l9ZEnjEY
August 3rd 2021, 11:08am
secalerts4u @secalerts4u
$MRNS - Current Report Filing (8-k) https://t.co/U0Jgr3BHiF
August 3rd 2021, 11:08am
quantisnow @quantisnow
$MRNS ? Marinus Pharmaceuticals Announces Exclusive Collaboration with Orion Corporation for European Commercializa… https://t.co/jt7jNyy4wQ
August 3rd 2021, 11:08am
stock_titan @stock_titan
$MRNS Marinus Pharmaceuticals Announces Exclusive Collaboration with Orion Corporation for European Commercializati… https://t.co/ojBLRfKEHq
August 3rd 2021, 11:08am
ZoZoStockwatch @ZoZoStockwatch
RT @TheTradeXchange: $MRNS: Marinus Pharmaceuticals Announces Exclusive Collaboration with Orion Corporation for European Commercialization…
August 3rd 2021, 11:08am
TheTradeXchange @TheTradeXchange
$MRNS: Marinus Pharmaceuticals Announces Exclusive Collaboration with Orion Corporation for European Commercialization of Ganaxolone
August 3rd 2021, 11:08am
bthefirsttoknow @bthefirsttoknow
$MRNS: Marinus Pharmaceuticals Announces Exclusive Collaboration with Orion Corporation for European Commercialization of Ganaxolone //First
August 3rd 2021, 11:08am
investor_feed @investor_feed
$MRNS 8-K Marinus Pharmaceuticals (3 Aug, 7:15am) ? Marinus Pharmaceuticals Announces Exclusive Collaboration… https://t.co/KVx0hWZLWh
August 3rd 2021, 11:08am
Beeken_health @Beeken_health
$MRNS - Marinus Pharmaceuticals Submits New Drug Application (NDA) to FDA for Ganaxolone for the Treatment of Seizu… https://t.co/8TwwAOS7Pm
August 3rd 2021, 11:08am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2021. All rights reserved.